Received Nov 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | UNK | U8874Aa | IM / RA |
On November 17, 2025, the patient presented to our retail pharmacy to receive a high-dose influenza (HD flu) vaccination. The pharmacist had previously consulted with the patient in October 2025, during which the patient elected to postpone vaccination until November based on the timing of his influenza immunization from the prior year. Upon the patient?s arrival, the pharmacist accessed and printed the patient?s record from the state Immunization Registry to review current immunization status and determine if any additional vaccines were due. Following administration of the HD flu vaccine, the pharmacist proceeded to document the dose in state system and subsequently noted that an existing record indicated the patient had already received an influenza vaccination at another location in October 2025. The duplicate administration was unintentional and identified immediately upon documentation review. The patient remained in the pharmacy for observation and exhibited no adverse reactions at the time of reporting.